Gastro Flashcards

1
Q

What are the indications for liver transplant?

A

Survival > 50% 5yrs post-transplant

  • MELD > 15
  • LIver disease with > 50% mortality at 2yrs if not transplanted
  • Diuretic-resistant ascites
  • Recurrent hepatic encephalopathy
  • Recurrent SBP
  • Recurrent or persistent GI haemorrhage
  • Intractable cholangitis
  • Hepatopulmonary syndrome
  • Portopulmonary HTN
  • Metabolic syndromes (with severe or life-threatening symptoms) that are curable with liver transplantation (eg. familial amyloidosis, urea cycle disorders, oxalosis)
  • Polycystic liver disease with severe or life-threatening symptoms
  • Intractable itch secondary to cholestatic liver disease
  • Hepatoblastoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the contraindications to liver transplantation?

A
Active illicit substance misuse
AIDS
Extrahepatic malignancy
Uncontrolled sepsis
Extrahepatic organ failure (lungs, heart). Pulmonary pressure > 50mmHg absolute contraindication.
Splanchnic thrombosis extending to SMA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the management principles in cirrhosis?

A
  • Weight loss if overweight => decreased mortality and HCC risk
  • Late evening high protein meal => reduced muscular catabolism
  • Coffee => 2 cups daily reduced all-cause mortality, fibrosis and HCC
  • Dark chocolate and Vit C => reduces post-prandial rise in HPVG
  • No EtOH. Baclofen if alcoholic + cirrhotic.
  • Smoking cessation => less fibrosis in Hep C, NASH, PBC. Improved post-transplant morbidity and mortality.
  • Vaccination: Hep A, Hep B, influenza, pneumococcus as early as possible

Portal HTN

  • Defined as HVPG > 5mmHg. Varices develop when HVPG > 10mmHg. Bleeding if HVPG > 12mmHg
  • SAAG ≥ 11 also defines portal HTN
  • Na restriction to <2g/day
  • Spironolactone 100mg/d (max 400mg/d) +/- frusemide 40mg/d (max 160mg/d)
  • Non-selective beta blockers (propranolol or carvedilol) to target BP<60. Ensure HR>50 and systolic BP>90. Also reduces incidence of spontaneous bacterial peritonitis. Contraindicated if refractory ascites, SBP, severe alcoholic hepatitis, or BP < 100 systolic.
  • Midodrine may increase U/O, urinary Na excretion, and MAP in those with stable hypotension.
  • Fluid restrict if Na < 120 (intake < urine output)

Varices

  • Banding if variceal bleeding
  • TIPSS if recurrent GI bleeds despite banding

Ascites
- Large volume paracentesis with 8g/L albumin IV (20g in 100mL of 20%) when drainage > 5L

Spontaneous bacterial peritonitis phrophylaxis

  • Secondary prophylaxis if previous SBP.
  • Bactrim DS 1 daily 1st line, norfloxacin 2nd line
  • Primary prophylaxis if ascites protein < 15/g AND renal impairment (Cr ≥ 110 or Ur ≥ 8.9 or Na ≤ 130) or liver failure (Child-Pugh ≥ 9 and bili ≥ 50)

Encephalopathy
- Lactulose and rifaximin

Meds

  • Avoid NSAIDs, ACEIs, aminoglycosides (renal impairment).
  • PPIs may increase risk of SBP.
  • Antihypertensives should cease (increased survival if systolic BP>82)
  • Limit paracetamol to 2g/d
  • If sedatives are necessary, use either loraz or oxaz (short acting); or trazodone 100mg nocte.
  • Use statins in NAFLD - mortality benefit

Transplantation discussion
Consider when MELD ≥ 17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which patients with chronic HBV infection should be treated?

A
  • Adults with immune-active CHB (HBeAg- or HBeAg+), defined by ALT >2 times ULN or evidence of significant histological disease and HBV DNA >2000 IU/mL (HBeAg negative) or >20,000 IU/mL (HBeAg positive)
  • Persons with immune-active CHB and cirrhosis if HBV DNA >2000 IU/mL, regardless of ALT level
  • Persons ˃40 years with normal ALT and elevated HBV DNA (≥1,000,000 IU/mL) and liver biopsy showing significant necroinflammation or fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Wha are the stages of chronic HBV infection?

A

Immune tolerant => immune active => inactive carrier => immune escape/reactivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which urinary markers can be used to distinguish between hepatorenal syndrome and ATN?

A

NGAL and IL-18 (elevated in ATN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the pharmacological treatment options in hepatorenal syndrome?

A

Albumin 1g/kg/d + terlipression OR
Albumin 1g/kg/d + octreotide + midodrine
CRRT
Liver-kidney transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do the MELD and UKELD scores predict?

A

3 month and 1 year mortality respectively

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the initial diuretic regime in cirrhosis with ascites?

A

Spironolactone 100mg daily + frusemide 40mg daily

Combined Rx better than sequential Rx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What assessment tools are available in Crohn’s Disease?

A

CDAI - Crohn’s Disease Activity Index (symptomatic)
CDEIS - Crohn’s Disease Endoscopic Index of Severity (inflammation assessment)
CRP and faecal calprotectin - inflammation
PROSPECT - web-based tool to predict risk of developing CD-related complications. Most important parameters are 1) disease location, 2) depth of lesions, 3) disease extent, and 4) young age of pt.

Treat early with biologics - better outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do you decide between biologic agents in Crohn’s Disease?

A

Anti-TNF
- Best results on mucosal healing
- Preferred in spondyloarthropathies or uveitis
- If deep fistulising disease, use anti-TNF + DMARD
Anti-integrin (vedolizumab)
- At 6-12 months, mucosal healing very good
- Preferred in concurrent skin disorders
Anti-IL12/23 (ustekinumab)
- Preferred in concurrent psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What conditions are associated with coeliac disease?

A
  • Aphthous ulcers and angular cheilitis
  • Dry skin, hair and nails
  • Dental problems: thin enamel
  • Neurological: ataxia, polyneuropathy, epilepsy
  • Cardiac: pericarditis, cardiomopathy
  • Fatty liver
  • NHL, particularly affecting the intestines
  • Dermatitis herpetiformis
  • Osteoporosis
  • IgA deficiency
  • Hyposplenism
  • Recurrent miscarriages
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Where is Fibroscan validated? What value excludes cirrhosis?

A

Validated in Hep C, pre-treatment

Elastography < 12.5kPa => excludes cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What APRI score excludes cirrhosis?

A

APRI < 1.0 => not cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the main micronutrient deficiency in gastric bypass patients?

A

Iron deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which serum parameters are low in protein-losing gastroenteropathy?

A
Albumin
Gamma globulins
Lymphocytes
A1AT
Fibrinogen
Cholesterol
Caeruloplasmin
Transferrin
Retinol - Vit A
Vit D
Alpha-tocopherol - Vit E
PIVKA-II (proteins induced in vitamin K absence)
17
Q

How is protein-losing gastroenteropathy diagnosed?

A

Elevated stool A1AT clearance

Alpha 1-antitrypsin clearance = (stool volume) x (stool alpha 1-antitrypsin)/ (serum alpha-1 antitrypsin)

18
Q

Intestinal lymphangiectasis (with protein loss) is associated with which conditions?

A
Secondary to IBD
Turner's syndrome
NF1
Yellow nail syndrome
Noonan's syndrome
Klippel–Trenaunay and Hennekam syndromes
19
Q

What are the treatment options in Wilson’s disease?

A
  • Lifelong penicillamine (given with pyridoxine)
  • Tetrathiomolybdate with zinc salts in those with neurological symptoms
  • TIPS in decompensated liver failure
20
Q

Which PSC patients are most likely to develop cholangiocarcinoma?

A

Those with PSC and UC (23% of patients).

Very unlikely in PSC + Crohn’s.

21
Q

How can EtOH intake be quantified?

A

AUDIT-C ≥3 for women or ≥4 for men

  • How often do you drink EtOH
  • How many standard drinks of EtOH would you drink on an average day?
  • How often do you drink 6 or more standard drinks in a day?

SADQ
- Designs by WHO to measure EtOH dependence

22
Q

Which patients should be considered for residential-assisted or inpatient withdrawal?

A
  • More than 30 units of EtOH daily
  • SADQ>30
  • Epilepsy or withdrawal-related seizures or delirium tremens during previous assisted withdrawal programs
  • Needs concurrent withdrawal from alcohol and benzodiazepines
  • Regularly drinks 15–20 units of alcohol a day and has psychiatric or physical comorbidities (eg. chronic severe depression, psychosis, malnutrition, CCF, unstable angina, chronic liver disease) or a learning disability or cognitive impairment
23
Q

What are the primary initial options in moderate to severe EtOH dependence?

A
  • Acamprosate or naltrexone (C/I in pregnancy, or severe hepatic or renal disease)
  • CBT focusing specifically on EtOH misuse